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Tumorigenic S49 mouse lymphoma cells (T-25) were compared to their nontumorigenic (immunogenic) substrate-adherent
descendants (T-25-Adh), using the differential display technique. A 784-bp fragment with 92% sequence homology to the
intracisternal A-particle (IAP) element family was isolated from the latter cells. IAP sequences are endogenous, noninfectious
retroviral elements that can undergo transpositions and act as mutagens. Expression of IAP transcripts (as detected by the
isolated fragment) was 5- to 10-fold higher in T-25-Adh cells than in T-25 cells. IAP RT-PCR cDNA clones derived from the
immunogenic T-25-Adh cells, but not from T-25 cells, contain two distinctive motifs: (i) a motif characteristic of IAP elements
expressed in lymphoid cells (lymphocyte specific, LS); (ii) a nonapeptide sequence known to stimulate cytotoxic T lympho-
cytes in a leukemia cell line expressing IAP sequences. In addition, expression of transcripts containing these motifs is
enhanced in the immunogenic cells as opposed to the tumorigenic cells. Furthermore, one of the IAP elements (belonging
to the LS1 subfamily) is specifically hypomethylated in the DNA of the immunogenic cells. The above-mentioned relationship
was strengthened when tumorigenic revertants derived from T-25-Adh cells, as well as independently selected tumorigenic
and immunogenic S49 sublines, were studied. In all cases, enhanced immunogenicity was linked to the up-regulation of
specific IAP elements. No transpositions of LS1 elements were observed among the different sublines studied. These
findings suggest that, in the S49 lymphoma, selectively expressed IAP retroviral elements may function in a tumor
suppressive capacity by affecting the immunogenic potential of these cells. © 2000 Academic Press
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eINTRODUCTION
Intracisternal A-particles (IAP) are defective retrovi-
ruses encoded by endogenous proviral elements.
There are approximately 1000 IAP-related elements
per haploid mouse genome, but only a limited number
are transcribed in normal cells (Mietz et al., 1992).
These elements are capable of transposition, as a
consequence of which they may either activate or
inactivate genes located adjacent to their integration
site. Indeed, transpositions of IAP are known to be
mutagenic when activation of oncogenes (Kuff, 1990;
Lee et al., 1999), growth factors (Lee et al., 1999), or
cytokines (Lee et al., 1999; Wang et al., 1997) or inac-
ivation of tumor suppressor genes (Xiao et al., 1995)
ccurs. Full-length elements are 7.2 kb long, but there
re also internally deleted elements that are assigned
nto subgroups. In most cases transpositions involved
eleted type ID1 IAP elements, which encode 5.4-kb
transcripts (Kuff and Lueders, 1988).
High-level expression of IAP has been described in
murine transformed cell lines as well as during normal
mouse embryogenesis. Extensive hypomethylation of1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 972-2-5617918. E-mail: hochman@vms.huji.ac.il.
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136IAP is found in a variety of tumors. Selective activation of
IAP is thought to stem from the methylation status of the
LTR (Falzon and Kuff, 1991; Morgan and Huang, 1984),
although the preferential presence of or the response to
transcription factors also plays a role (Falzon and Kuff,
1990). Very few IAP elements are hypomethylated in
normal cells and these have been shown to belong to
distinctive IAP element subfamilies that are expressed in
normal B and T lymphocytes (Mietz et al., 1992). These
ranscripts contain a 9-nucleotide motif, named LS (for
ymphocyte specific), in the R region that is used to
lassify IAP LTRs from normal lymphocytes into three
lasses, LS1, LS2, and LS3.
In our laboratory, we have selected several variants of
he S49 murine T cell lymphoma, manifesting different
umorigenic and immunogenic characteristics. Highly tu-
origenic (median survival 14 days) suspension-borne
ariants (named T-25) were selected from parental S49
ells, following 25 consecutive in vivo passages (Hoch-
an et al., 1981, 1984). From T-25 cells, substrate-adhe-
ive variants, named T-25-Adh, were selected. T-25-Adh
ells showed impaired tumorigenicity and enhanced im-
unogenicity (protection against a challenge with tumor-
genic T-25 cells) in immunocompetent mice (Hochman
t al., 1981, 1984, 1990; Mador et al., 1997). We haveapplied several approaches to study the differences be-
tween T-25 and T-25-Adh cells. Thus, we described a
om
T
a
t
f
T
s
f
n
t
a
s
T
I
a
i
o
m
l
u
a
c
s
m
i
p
s
1
p
i
o
v
l
W
(
t
c
n
s
a
c
t
l
n
s
D
e
s
t
h
l
p
137DIFFERENTIAL EXPRESSION OF IAP IN S49 LYMPHOMAdistinct mutation, specific to each cell line, in the p53
tumor suppressor gene (Bergel et al., 1993). It was also
bserved that mouse interferon-a (IFN-a) and IFN-b se-
lectively affect the morphogenesis of intracellular MMTV-
related precursors in T-25-Adh cells, thereby enhancing
their immunogenicity (Mador et al., 1997). Additionally, a
novel protein (p21) derived from the env precursor of the
ouse mammary tumor virus is expressed in nucleoli of
-25 cells but not in T-25-Adh cells (Hoch-Marchaim et
l., 1998).
In the present study, we applied the differential display
echnique (Welsh et al., 1992) to further investigate dif-
erences of potential biological significance between
-25 and T-25-Adh cells. These cells are particularly
uitable for this approach since the latter were derived
rom the former via a spontaneous selection process and
ot through induced mutagenesis, while they are pheno-
ypically distinct in terms of cell adhesion, tumorigenicity,
nd immunogenicity (Hochman et al., 1984). We demon-
trate enhanced expression of the LS family of IAP in
-25-Adh cells compared to T-25 cells. In fact, increased
AP expression is inversely correlated to tumorigenicity
nd directly correlated to immunogenicity also in other
ndependently selected S49 sublines isolated in our lab-
ratory. We also show that a specific LS1-type IAP ele-
ent is hypomethylated in the sublines that express high
evels of IAP.
RESULTS
The relationship among the different S49 sublines
sed in this study is depicted in Fig. 1 (see Materials
nd Methods for derivation of cells). S49 lymphoma
ells have been selected in vivo for highly tumorigenic,
uspension-borne cells through multiple passages in
ice. These cells have, in turn, been selected for an
mmunogenic, nontumorigenic adhesive cell line sim-
ly through spontaneous in vitro selection for cell-
FIG. 1. Relationship between different sublines of the S49 lineage. In
vitro growth characteristics are given in parentheses.ubstrate adhesiveness over several generations (Fig.
). Both of these selection processes have been re-
a
Teated with similar resulting cell phenotypes, indicat-
ng the reproducibility of this method (Fig. 1). More-
ver, UV irradiation of T-25-Adh cells followed by in
itro selection for growth in suspension culture al-
owed the selection of revertant, tumorigenic cell lines.
e were able to isolate both a highly tumorigenic
single cell) suspension-growing cell line and a less
umorigenic cell line, which grows in suspension as
lumps (Fig. 1). It is noteworthy that the latter subline,
amed Rev-2-T-6, is also immunogenic, since mice
urviving inoculation of these cells are protected
gainst a subsequent challenge with tumorigenic T-25
ells (Braun and Hochman, unpublished data). We,
hus, have at our disposal a wide spectrum of cell
ines, constituting a full cycle from tumorigenic to
ontumorigenic cells and back to the tumorigenic
tate, all derived from the parental S49 cell line.
ifferentially expressed mRNA in T-25-Adh cells
Differential display was performed to analyze differ-
ntially expressed genes in the nontumorigenic, sub-
trate adherent T-25-Adh cells in comparison with the
umorigenic, suspension-borne T-25 cells (Fig. 2). A
igh degree of similarity exists between the two cell
ines, as shown by the preponderance of identical
FIG. 2. Differential display of T-25-Adh and T-25 cells. mRNA was
isolated, reverse-transcribed, and PCR-amplified in two indepen-
dent reactions shown in duplicate. The 17-mer primer 59-CCTCCGC-
GAGATCATCT-39 was used in the presence of 35S-dATP. The PCR
roducts were separated on a 4% acrylamide denaturing gel. The
rrow indicates a fragment (Lym-IAP) present in the nontumorigenic
-25-Adh cells that was further analyzed.
putative nonapeptide (absent from MIA14) is indicated as an open box
(see also Fig. 8).
s
U5, start of the U5 region; gag, start of the gag gene. Arrows indicate the start (
but duplicated in the T-25-Adh clones. Dots indicate identical bases; dashes
138 BRAUN ET AL.bands in this and other experiments (not shown) using
different arbitrary primers. However, several differen-
tially expressed bands are evident in each cell line. In
this work, one 784-bp band, named Lym-IAP (Fig. 2),
was eluted from the gel, amplified, cloned into the pCRII
vector, and verified by Northern blot analysis to be differ-
entially expressed in T-25-Adh cells (see below).
Sequence analysis of cDNAs
Sequencing of the Lym-IAP cDNA followed by data-
bank search revealed strong similarity with the DNA of
endogenous defective retroviruses that belong to the
murine IAP element family (see Fig. 3). Homology of
92% over 714 bp was found with the prototype MIA14-
IAP sequence (Fig. 4) (Mietz et al., 1987). The Lym-IAP
S49 cells and the MIA14 IAP element. Sequences compared were as
dh(1) and T-25-Adh(2) derived from the immunogenic T-25-Adh cells
s T-25(1) and T-25(2) derived from the tumorigenic T-25 cells (GenBank
IA14 [(Mietz et al., 1987), GenBank Accession No. M17551]. CT repeat
es indicate LS1 and LS2 regions, respectively. R, start of the R region;
Þ
xFIG. 3. Location of Lym-IAP cDNA along the MIA14 IAP genomic
element. Alignment of Lym-IAP with MIA14 IAP [(Mietz et al., 1987),
GenBank Accession No. M17551] starts at position 222 of MIA14 IAP.
HaeII and HindIII sites are indicated (see also Fig. 7). LS sequences
are indicated as solid boxes (see also Fig. 4). The sequence of aFIG. 4. Nucleotide sequence comparison of IAP cDNA clones derived from
follows: Lym-IAP (GenBank Accession No. AF303450); RT-PCR clones T-25-A
(GenBank Accession No. AF303451 and AF303452, respectively); RT-PCR clone
Accession No. AF303453 and AF303454, respectively); the genomic element M
equences in the R region are indicated by an overline. Shaded and open box
) and end ( ) of a sequence present in one copy in the T-25 clones,
represent gaps introduced to enhance alignment.
x
Þ
139DIFFERENTIAL EXPRESSION OF IAP IN S49 LYMPHOMAsequence spans the MIA14-IAP sequence from the R
region in the 59 LTR through the first 255 nucleotides
of the gag gene (Fig. 4).
The R region of IAP demonstrates extensive variability
due to duplication of a CT-rich region (Christy et al.,
1985). The R region of Lym-IAP contains six copies of the
CT-rich 13-nucleotide repeat, CTCTCTCTTGCTT (Fig. 4).
This sequence was previously shown to exist in two to
six copies arranged in tandem in IAP cDNA clones de-
rived from normal LPS-stimulated lymphocytes (Mietz et
al., 1992) and from BL6 melanoma cells (Li et al., 1996).
These repeats are followed by a 9-nucleotide motif
(named LS) in the R region. These LS motifs appear as
three subtypes, LS1 (CCCCAAAAA), LS2 (CCCGATAAA),
and LS3 (CCCCATAAA), which are used to classify IAP
from normal lymphocytes into the three corresponding
classes: LS1, LS2, and LS3. Oligonucleotide probes that
distinguish these three classes detect a limited number
of IAP proviral copies in mouse genomic DNA (Mietz et
al., 1992).
The Lym-IAP sequence was further compared (Fig.
4) to cDNA clones derived from the immunogenic
T-25-Adh cells, named T-25-Adh(1) and T-25-Adh(2), as
well as cDNA clones derived from the highly tumori-
genic T-25 cells, named T-25(1) and T-25(2). These
clones were obtained through RT-PCR using primers
constructed from the 59 and 39 ends of Lym-IAP (see
Materials and Methods). The cDNA clones derived
from T-25-Adh cells contain LS motifs. Clone Lym-IAP
contains the LS1 motif CCCCAAAAA, while clones
T-25-Adh(1) and T-25-Adh(2) contain the LS2 motif
CCCGATAAA. The clones derived from T-25 cells, as
well as MIA14, contain a sequence different from the
LS motif in this region (Fig. 4).
Additional differences in sequence are manifested
between the cDNAs expressed in T-25-Adh cells and
those expressed in T-25 cells, while the clones within
each group share a high degree of similarity. These
differences are evident in the region that spans from
nucleotide 217 to the beginning of the gag gene (Fig.
4). Another difference between the two groups is the
sequence at positions 293–333, present in only one
copy in the T-25 clones, but duplicated at positions
374–413 in the T-25-Adh clones. This region is known
to be variable and to contain direct and inverted re-
peats (Christy et al., 1985).
Immunogenic sublines express high levels of IAP
transcripts
Messenger RNA from T-25 and T-25-Adh cells was
analyzed using the Lym-IAP fragment as a probe (Fig. 5).
This probe detected two transcripts: a major transcript of
5.4 kb and a minor transcript of 7.2 kb in both T-25 and
T-25-Adh cells. The expression of the 5.4-kb transcript
was 5- to 10-fold higher in T-25-Adh cells than in T-25cells, as analyzed by densitometry. Low-level expression
of IAP transcripts was also found in an ascites tumor of
T-25 cells (not shown), suggesting that the decreased
expression is not due to the in vitro culture conditions of
these cells.
To examine IAP expression in our lymphoma model,
we analyzed its expression in the other S49-derived
sublines (Fig. 1). In addition to T-25-Adh, both X-18-Adh
and Rev-2-T-6 express high levels of IAP transcripts
(Fig. 5). On the other hand, the tumorigenic S49 sub-
lines X-18 and Rev-1(Ta) (Fig. 1) demonstrate de-
creased expression of the 5.4-kb transcripts, similar to
T-25 cells. It is evident from the results that immuno-
genic sublines (T-25-Adh and X-18-Adh) express high
levels of IAP transcripts, while their parental tumori-
genic sublines (T-25 and X-18) do not. Moreover,
during the selection for tumorigenic revertants the
capability of expressing IAP transcripts was lost. Rev-
2-T-6 cells, which express high levels of IAP tran-
scripts, constitute a special case. On one hand, these
cells are tumorigenic, albeit less aggressive than T-25,
X-18, and Rev-1(Ta). On the other hand, they are ca-
pable of immunizing mice against the highly tumori-
genic cells.
LS-type IAP elements are highly expressed in the
immunogenic sublines
Northern blot analysis using the LS2 sequence as a
probe (Fig. 6) detects a 5.4-kb transcript in the immuno-
genic T-25-Adh, X-18-Adh, and Rev-2-T-6 mRNAs, while
only a faint band is seen in the highly tumorigenic T-25,
X-18, and Rev-1T(a) mRNAs. When LS1 was used as a
probe, both 5.4- and 7.2-kb transcripts were detected.
The levels of the 5.4-kb transcripts were higher in T-25-
Adh than in T-25 mRNA (not shown). Thus, the selective
expression of IAP seen in the immunogenic sublines
with the Lym-IAP probe is also seen when the LS se-
quence was used as a probe. LS1 transcripts of 5.4 and
FIG. 5. Northern blot analysis of mRNA from S49 sublines hybridized
to the Lym-IAP fragment and b-actin.7.2 kb and the LS2 transcript of 5.4 kb are typically
expressed in normal lymphocytes (Mietz et al., 1992).
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140 BRAUN ET AL.LS1-type IAP elements are located at the same
genomic positions in both the immunogenic and the
tumorigenic sublines
Based on the sequence analysis described above, we
used the LS1-oligo probe to examine the various S49 cell
lines for possible transpositions of IAP in the genome
(Fig. 7a). As IAP have a conserved HindIII site just 39 to
the LS element in the LTR, digestion with this enzyme
results in fragments that represent IAP 59-flanking se-
quences (see Fig. 3). Thus, each fragment on the gel
represents a single LS1 element locus out of 31 that are
present in the BALB/c mouse genome (Mietz and Kuff,
FIG. 6. Northern blot analysis of mRNA from S49 sublines hybridized
to LS2 oligonucleotide probe and b-actin.
FIG. 7. Genomic location and methylation status of IAP LS1 eleme
oligonucleotide probe. (b) DNA from S49 sublines was cut with HindIII
robe. *HindIII lanes are the same in both a and b. A hypomethylated
rrowheads. A hypomethylated fragment (cut with HaeII) specific for T-25, X-
ragments common to all sublines are marked with arrows.1992). The present analysis did not show any differences
in the number or position of IAP LS1-type elements in the
majority of DNAs. The one exception is Rev-1T(a) cells,
whose DNA showed both deletions and additions of LS1
IAP loci.
High-level expression of IAP is correlated with
hypomethylation of a specific LS1-type IAP element in
the immunogenic sublines
Development of the oligonucleotide probes that detect
a restricted number of IAP elements has made it possi-
ble to carry out an analysis of the hypomethylation state
of individual loci on conventional one-dimensional gels
(Lueders et al., 1993a). This method was used to show
hat established plasmacytomas exhibit a characteristic
attern of IAP hypomethylation when compared to nor-
al liver cells (Lueders et al., 1993a). The technique was
lso used to show that similar patterns of hypomethyla-
ion are seen in established and primary mouse plasma-
ytomas (Lueders and Kuff, 1995). A single conserved
ethylation-sensitive HaeII site in the LTR (see Fig. 3)
akes it possible to assess the methylation status of
ndividual IAP loci. When the restriction fragment pattern
f a HindII digest is compared with that of a HindIII 1
aeII digest (Fig. 7b, compare lanes H to lanes H/Ha),
ny hypomethylated fragments will disappear or become
horter after HaeII digestion. As can be seen (Fig. 7b,
arked with solid arrowheads), a single fragment is
DNA from S49 sublines was cut with HindIII and hybridized to LS1
H) or with HindIII and HaeII (H/Ha) enzymes and hybridized to the LS1
nt specific for T-25-Adh, X-18-Adh, and Rev-2-T-6 is marked with solidnts. (a)
alone (
fragme18, and Rev-1T(a) is marked with open arrowheads. Hypomethylated
ccessio
141DIFFERENTIAL EXPRESSION OF IAP IN S49 LYMPHOMAhypomethylated in the immunogenic T-25-Adh, X-18-Adh,
and Rev-2-T-6 cells, while a different fragment is hypo-
methylated in the highly tumorigenic T-25, X-18, and
Rev-1-T(a) cells (Fig. 7b, marked with open arrowhead).
Two other fragments are hypomethylated in all S49 sub-
lines (Fig. 7b, marked with arrows).
Differences in predicted amino acid sequence among
S49 sublines
The deduced amino acid sequence of T-25 and T-25-
Adh cDNA clones was compared (Fig. 8). The sequence
includes 80 amino acids from the N-terminus of the IAP
gag protein. The comparison starts from the first methi-
onine of the p73 gag protein of the MIA14 IAP element
(Fig. 8, bottom line). Two regions show distinct sequence
differences among the clones. A leucine-zipper motif,
known to be part of a nuclear DNA binding site in
molecules such as transcription factors, is present in
Lym-IAP as well as T-25-Adh(1) and T-25-Adh(2) cDNA
clones, but not in T-25(1) and T-25(2) cDNA clones.
Another unifying feature shared by clones Lym-IAP,
T-25-Adh(1), and T-25-Adh(2) is a stretch of 9 amino acids
(RRNGKYTGL) at position 49–61. A databank search for
this nonapeptide-encoding sequence (27 bases) re-
vealed three IAP elements that share this region (Gen-
Bank Accession Nos. U70139.1 and S74315 and EMBL
Accession No. X04120). Among them is a very similar
nonapeptide (8/9 amino acid identity) present in the IAP
gag region of a mouse leukemia (LEC) cell line (de
Bergeyck et al., 1994) (see Fig. 8). This nonapeptide
induced an immune response toward LEC cells by stim-
ulating cytotoxic T lymphocytes (CTLs) (de Bergeyck et
al., 1994). It is noteworthy that the cDNA clones derived
from the tumorigenic T-25 cells manifest a somewhat
different sequence (KRKYGTQNKYTGL), suggesting that
expression of the nonapeptide could be instrumental in
the regulation of this phenotype. Northern blot analysis
using an oligonucleotide probe encoding the nonapep-
tide sequence detected a 5.4-kb transcript in the immu-
nogenic T-25-Adh, X-18-Adh, and Rev-2-T-6 lanes, corre-
sponding to the ID1-type IAP element (Kuff and Lueders,
1988). Only a faint band of 5.4 kb is seen in the tumori-
FIG. 8. Predicted amino acid sequence comparison of the gag gene (
IAP and LecA IAP elements. Sequences compared were the same
leukemia-derived IAP element [(de Bergeyck et al., 1994), GenBank A
homologues. An open box indicates a leucine-zipper motif.genic T-25, X-18, and Rev-1-T(a) lanes (Fig. 9), thus sup-
porting the sequence data from T-25 and T-25-Adh cDNAclones. From the sequence data of T-25-Adh clones (Fig.
4), it is evident that both LS1 and LS2 IAP transcripts
contain the nonapeptide sequence.
DISCUSSION
In the present study we show that, in S49 lymphoma
sublines, there exists a linkage between cell adhesive-
ness, impaired tumorigenicity, and enhanced immunoge-
nicity. The single-cell suspension growing T-25 and X-18
sublines are highly tumorigenic (Fig. 1), while the sub-
strate adhering variants derived from them (T-25-Adh and
X-18-Adh, respectively) are nontumorigenic and immuno-
genic. Furthermore, suspension (single cells) growing
revertants (Rev-1-Ta) derived from T-25-Adh cells are
highly tumorigenic, similar to the original T-25 cells. Rev-
2-T-6 cells constitute a special case that strengthens the
above-mentioned linkage. These cells, derived from
T-25-Adh cells, grow in suspension as clumps and,
therefore, represent partial revertants (cell–cell adher-
ence) between substrate adhering cells and single cells
in suspension. These cells also demonstrate partial re-
version of tumorigenicity and immunogenicity, insofar as
(i) mice inoculated with Rev-2-T-6 cells demonstrate ex-
tended survival (Fig. 1) and (ii) mice that do not develop
tumors upon inoculation of these cells are immunized
against subsequent challenges with parental T-25 cells.
The differential display technique has been used suc-
cessfully to delineate differences in gene expression
amino acids) from IAP cDNA clones derived from S49 cells with MIA14
se described in the legend for Fig. 4, with the addition of LecA, a
n No. S74315]. Shaded boxes indicate the LecA nonapeptide and itsfirst 80
as thoFIG. 9. Northern blot analysis of mRNA from different S49 sublines
hybridized to the nonapeptide and b-actin probes.
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142 BRAUN ET AL.between closely related cells. In the present study, we
have used this technique to investigate the S49 sublines
that differ in tumorigenicity, immunogenicity, and adher-
ence. We found that enhanced expression of IAP ele-
ments is tightly correlated with impaired tumorigenicity
and enhanced immunogenicity. Thus, S49 sublines that
are immunogenic (T-25-Adh, X-18-Adh, and Rev-2-T-6
cells) demonstrate a 5- to 10-fold increase in IAP tran-
scripts over S49 sublines that are highly tumorigenic
[T-25, X-18, and Rev-1T(a)]. During the transition from
tumorigenic to nontumorigenic S49 cells, up-regulation
of IAP expression occurs. This is followed by down-
regulation of IAP expression when the nontumorigenic
S49 cells revert to full-fledged tumorigenicity, thereby
constituting a full cycle from tumorigenic to nontumori-
genic cells and back to the tumorigenic state. The im-
munogenic Rev-2-T-6 cells, which are, phenotypically, in
an intermediate stage (median survival of ;80 days,
grow in suspension culture as clumps and solid tumors
in vivo), demonstrate an IAP transcript level similar to
that of T-25-Adh and X-18-Adh cells. This may indicate
that Rev-2-T-6 cells have not undergone the final steps to
full-fledged tumorigenicity and suspension-borne single
cells, following their selection from mutagenized T-25-
Adh cells.
Other studies have also demonstrated an association
between IAP expression and in vitro or in vivo charac-
eristics of different cells. In general, transformed cell
ines were found to express larger amounts of IAP tran-
cript than normal tissues, although few studies have
ttempted to correlate expression levels with varying
evels of tumorgenicity within the same system. A corre-
ation similar to ours between reduced tumorigenicity
nd enhanced expression of IAP was shown in hybrids
f myeloma and fibroblast cells, in comparison to their
arental myeloma cells. The reduced tumorigenicity of
he hybrid cells was postulated to be the result of sup-
ression of the translocated myc gene (Laskov et al.,
991). Increased IAP expression was also seen in ras-
ransformed NIH 3T3 cells treated with azatyrosine
Krzyzosiak et al., 1992). These cells became flat, showed
ontact inhibition, and scarcely formed tumors in nude
ice. It was suggested that IAP, among other activated
enes, act cooperatively to counteract ras function. In
nother study, IAP mRNA levels were 5- to 10-fold higher
n SEWA sarcoma cells derived from an ascites tumor
han in SEWA cells derived from a solid tumor (Ronai et
l., 1992). The cells derived from the ascites tumor grew
s multicellular spheroids and as single cells in suspen-
ion, while the cells derived from the solid tumors grew
ttached to the culture plate with a fibroblast-like mor-
hology. These results are in contrast to our findings in
49 cell variants. However, no difference regarding the
umorigenicity of the SEWA sublines was reported. The
bove-mentioned studies did not provide any information
s to which subclass of IAP elements was expressed.
b
lWe have shown that the IAP elements selectively ac-
ivated in T-25-Adh, X-18-Adh, and Rev-2-T-6 cells belong
o the LS IAP family. Thus, while T-25-Adh transcripts are
erived from the LS1 and LS2 genomic elements, T-25
ranscripts are derived from other elements, similar to
he prototype MIA14-IAP. The LS1 oligonucleotide re-
cted with transcripts of 7.2 kb (corresponding to the
ull-length type-I IAP elements) as well as 5.4 kb (repre-
enting ID1-type IAP elements), while the LS2 oligonu-
leotide detected only 5.4-kb transcripts. The same pat-
ern of hybridization with the LS-type IAP transcripts was
eported previously in normal BALB/c lymphocytes
Mietz et al., 1992). The study showed that IAP transcripts
n normal mouse thymus and activated B cells were
argely derived from a few selectively activated and
losely related proviral elements. Furthermore, LS ele-
ents are activated in both LPS-stimulated spleen cells
nd several plasmacytomas. In normal lymphocytes,
owever, the LS subpopulation is the major transcription-
lly active group of IAP elements in the thymus of several
nbred mouse strains (Mietz et al., 1992). The fact that, in
ur study, the pattern of LS1 and LS2 expression was
imilar to that found in hybridization with the more gen-
ral IAP probe (Lym-IAP) suggests that, as for normal
ymphocytes, the major transcriptionally active IAP ele-
ents in the immunogenic sublines belong to the LS
ubfamily.
One cannot know how many genomic IAP elements
re induced in the nontumorigenic (immunogenic) S49
ublines or how many of these are of the LS family.
owever, the findings that (i) sequence analysis of a few
-25-Adh and T-25 cDNA clones demonstrates LS motifs
n the former but not in the latter, (ii) specific probes (for
S and nonapeptide sequences) demonstrate selective
xpression of 5.4-kb transcripts in T-25-Adh vs T-25
RNAs, and (iii) a general probe (Lym-IAP, which sup-
osedly recognizes all IAP transcripts) shows activation
f 5.4-kb transcripts in T-25-Adh vs T-25 cells are all
onsistent with the notion that the LS family represents
he majority of the IAP elements that undergo activation
n T-25-Adh vs T-25 cells.
IAP elements may undergo transpositions and act as
ndogenous mutagens. Novel integration events of IAP
re known to activate or inactivate growth factor genes,
ytokine genes, proto-oncogenes, and tumor suppressor
enes during tumor progression (Kuff, 1990). We found
o difference in IAP integration sites between the immu-
ogenic and the tumorigenic S49 sublines. The only
ubline that shows different integration sites is Rev-
T(a). This may be due to the UV irradiation applied
uring the process of their generation (Bergel et al.,
993). As an example of UV irradiation causing retro-
ranspositions, it was shown (Servomaa and Rytomaa,
990) that after UV treatment, 300,000 copies of L1 mo-
ile DNA elements were inserted into apparently random
ocations in the cell genome. L1 elements frequently
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143DIFFERENTIAL EXPRESSION OF IAP IN S49 LYMPHOMAoccur in the 59 flanks of IAP elements (K. Lueders, un-
published observation). It is therefore conceivable that
UV treatment may cause insertion of L1 elements up-
stream of the LS1-IAP elements, thereby creating a new
HindIII site. The Rev-1(Ta) pattern also has new shorter
fragments that could have come from those that disap-
peared. The finding that no transpositions occurred in
the other S49 sublines rules out the possibility that dif-
ferences among integration sites in these cells play a
role in regulating other gene activity or affect the expres-
sion of IAP itself.
Selective activation of IAP may stem from the prefer-
ential presence of, or the response to, transcription fac-
tors (not addressed in this study) or the methylation
status of the LTR. Several studies have demonstrated
that the transcriptional activation of IAP elements is in-
fluenced by the DNA methylation state (Dupressoir and
Heidmann, 1996; Lueders et al., 1993a; Lueders and Kuff,
1995; Mietz et al., 1992; Walsh et al., 1998). Methylation
nhibits the binding of transcription factors to the IAP LTR
nd thereby inhibits its subsequent activation (Falzon
nd Kuff, 1991; Lamb et al., 1991). Alterations in DNA
ethylation are common in cancer cells and are capable
f directly modifying carcinogenesis (Jones, 1996; War-
ecke and Bestor, 2000). In plasmacytoma cells, addi-
ional IAP elements are activated compared to normal
PS-stimulated lymphocytes (Lueders et al., 1993a). In
he present study, hypomethylation of individual IAP loci
hat was demonstrated in the immunogenic sublines is
ssociated with enhanced IAP transcription in these
ells. However, this is not the case for the tumorigenic
49 sublines, in which hypomethylation is not associated
ith enhanced IAP transcription.
Another point of interest arises from the sequence
nalysis of the IAP clones. In addition to the leucine
ipper motif, the clones derived from T-25-Adh cells con-
ain a sequence encoding a putative nonapeptide. Our
ttention has been drawn to this particular sequence,
ince this nonapeptide was previously shown to be im-
unogenic in LEC leukemia cells (de Bergeyck et al.,
994). The nonapeptide sequence was recognized by
TLs when presented by H-2Dk molecules in LEC cells
nd it therefore has been considered a T-cell-defined
umor viral antigen (Van den Eynde and van der Bruggen,
997). The correlation between the presence of the non-
peptide sequence and immunogenic phenotype is
trengthened by the Northern blot findings that tran-
cripts containing the nonapeptide are selectively ex-
ressed in the immunogenic S49 sublines. Indeed, anti-
odies to human IAP (HIAP) have been found in the
erum of patients with autoimmune disorders, such as
raves’ disease (Jaspan et al., 1996), primary biliary
irrhosis (Mason et al., 1998), lupus erythematosus (Ma-
on et al., 1998), idiopathic CD4 T lymphocytopenia
Garry et al., 1996), and Sjogren’s syndrome (Garry et al.,990). It is now believed that HIAP is etiologically linked
o the above-mentioned autoimmune diseases.
Based on our findings and the studies cited above, it is
empting to speculate that the in vitro selection for cell
dhesiveness causes up-regulation of specific IAP ele-
ents of the LS subfamily. Hypomethylation in the LTR
egion of these elements may result in enhanced tran-
cription and expression of a specific nonapeptide. The
n vivo expression of such a nonapeptide may enhance
he immunizing potential of these cells against a subse-
uent challenge with suspension growing tumorigenic
49 cells. Is the expression of IAP instrumental in the
egulation of cell adhesiveness, tumorigenicity, and im-
unogenicity in S49 cells or is it a marker tightly linked
o the above phenotypes? Further experiments are
eeded to determine the primary targets of IAP element
xpression in the experimental model described in the
resent study. However, our results, whereby a full cycle
rom tumorigenic to nontumorigenic cells and back is
ssociated with enhanced expression and lack thereof
f specific IAP transcripts, suggest that, in S49 lym-
homa, the former possibility may be the case. IAP may
e seen, therefore, to act in an immunogenic and/or
umor suppressive capacity in these cells.
MATERIALS AND METHODS
ell lines
Cells were grown at 37°C in Dulbecco’s modified
agle’s medium containing 10% horse serum, penicillin
50 U/ml), and streptomycin (50 mg/ml), in a humidified
atmosphere containing 5% CO2.
T-25-Adh cells were derived from T-25 cells through
spontaneous selection for cell substrate adherence as
previously described (Hochman et al., 1981, 1984). A
similar selection procedure (from suspension to adhe-
sive cells) was applied to X-18 cells (descendants of a
different clone of S49 cells) subjected to 18 consecutive
in vivo passages (Hochman et al., 1981). Here again, the
substrate adherent cell variants (named X-18-Adh) were
nontumorigenic and immunogenic. T-25-Adh cells were
subsequently subjected to UV mutagenesis and in vitro
selection for suspension-borne revertants followed by in
vivo selection for tumorigenic cells. These revertants,
named Rev-1T(a), grew in suspension culture as single
cells and were highly tumorigenic (similar to the parental
T-25 cells) (Bergel et al., 1993). In another independent
UV selection experiment, we obtained suspension-borne
revertants, named Rev-2-T-6 (Assaf et al., 1997). Rev-2-T-6
cells grow in suspension culture, but as clumps, and
develop progressive tumors, albeit with extended sur-
vival. Thus, while T-25, X-18, and Rev-1T(a) cells are
highly tumorigenic (median survival of approximately 14,
23, and 17 days, respectively), Rev-2-T-6 cells develop
progressive tumors that are less aggressive (median
survival of approximately 80 days) and T-25-Adh and
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144 BRAUN ET AL.X-18-Adh are nontumorigenic in syngeneic mice. All sub-
lines were inoculated intraperitoneally into syngeneic
BALB/c mice at a dose of 107 cells per mouse.
RNA isolation
Total RNA was extracted with Trizol reagent (Gibco
RL, Life Technologies, Grand Island, NY) a mixture of
uanidine isothiocyanate, phenol, and 2-mercaptoetha-
ol, according to the manufacturer’s instructions. mRNA
as purified by the PolyAtract mRNA Isolation System
Promega, Madison, WI) that utilizes biotinylated oli-
o(dT), which hybridizes to streptavidin-coated magnetic
eads.
RNA differential display
mRNA was used for differential display, which was
erformed essentially as described by Welsh et al.
1992). mRNA (400 ng) was reverse-transcribed in a total
eaction volume of 20 ml containing reverse transcriptase
buffer [50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM
MgCl2], 10 mM DTT, a 200 mM concentration of each
dNTP, 20 units of RNase inhibitor (RNasin Ribonuclease
Inhibitor, Promega), a 1 mM concentration of the arbi-
rarily chosen 17-mer primer 59-CCTCCGCGAGATCATCT-
9, and 200 units of reverse transcriptase (SuperScript II
Nase H2; Gibco BRL). The reaction was carried out at
42°C for 1 h followed by 95°C for 5 min. Half of the cDNA
was then amplified by PCR in a total volume of 50 ml
ontaining Taq polymerase buffer [10 mM Tris–HCl (pH
), 50 mM KCl, 1.5 mM MgCl2, 0.1% Triton X-100, 0.2
g/ml BSA], a 1 mM concentration of the primer used for
reverse transcription, 0.05 mCi/ml [a-32P]dATP, and 1 unit
f Red Hot polymerase (Advance Biotechnologies, Sur-
ey, UK). The reaction mixture was subjected to the fol-
owing cycling parameters: one cycle of 94°C for 5 min,
0°C for 5 min, and 72°C for 5 min followed by 30
igh-stringency cycles: 94°C for 1 min, 55°C for 1 min,
nd 72°C for 2 min followed by 72°C for 5 min. The
mplified cDNAs were then separated on a 4% acryl-
mide denaturing gel. The reactions showing differen-
ially expressed bands were repeated to ensure repro-
ucibility.
ecovery of cDNA, reamplification, and TA cloning
The cDNA bands representing differentially expressed
RNAs were excised from the gel, rehydrated in 100 ml
distilled H2O for 10 min, and boiled for 10 min. Precipi-
ation was performed in 250 ml ethanol containing 10% 3
sodium acetate (pH 5.2) and 40 mg glycogen. The
dried pellet was redissolved in 10 ml distilled H2O. For
each band, 3 ml cDNA was reamplified for 30 cycles in a
total volume of 50 ml with the same primer and PCRonditions as in the initial PCR, except that no radioac-
ive dATP was included. The reamplified product was
m
7loned into the pCRII vector using the TA cloning system
InVitrogen, San Diego, CA).
orthern blot analysis
mRNA (1.5 mg) was electrophoresed in formaldehyde-
containing 1% agarose gels and transferred to nylon
membranes using standard techniques. The cDNA probe
was labeled with [a-32P]dCTP using a Random-Prime
NA labeling kit (Promega). Oligonucleotide probes
ere end-labeled with T4 polynucleotide kinase (Pro-
ega) and [g-32P]ATP. Oligonucleotide probes were as
ollows: LS1 probe, 59-CTTACATCTTTTTGGGGCCAGAG-
9; LS2 probe, 59-CTTACATCTTTATCGGGCCAGAG-39;
onapeptide probe, 59-GTATACTTACCGTTTCTCCTTGC-
9. For the Lym-IAP probe, the hybridization solution
onsisted of 50% formamide, 43 SSPE, 23 Denhardts’
olution, 0.1% SDS, 12.5% dextran sulfate, and 100 mg/ml
of salmon sperm DNA. Hybridization was performed at
42°C for 18 h, followed by one wash with 23 SSC, 0.5%
DS at 42°C and a second wash with 0.13 SSC, 0.1%
DS at 65°C. To determine the amounts of mRNA loaded
n each lane, the blots were hybridized with a b-actin
robe. Hybridization conditions for the oligonucleotide
robes were done according to Lueders et al. (1993b).
NA sequencing and analysis
Cloned reamplified PCR fragments were sequenced
y Dye Terminator Cycle Sequencing with an ABI Prism
77 DNA Sequencer (Perkin–Elmer) and analyzed using
equencing Analysis software. Identification of known
equences was performed using the Wisconsin Package
ersion 9.0, Genetics Computer Group (GCG), Madison,
isconsin.
T-PCR
Primers were constructed using the sequence of a
loned fragment (see Lym-IAP, Fig. 4) isolated from the
ifferential display reaction. The upstream primer was
9-TCTCTCTTGCTTCTTACACTC-39 (a primer that does
ot include LS sequence) from position 72–92 (Fig. 4).
he downstream primer was 59-TCCTTCTAATCTCTC-
CC-39, complementary to the sequence in position 759–
76 (Fig. 4) of the clone Lym-IAP. One microgram of total
NA was reverse-transcribed (as for the differential dis-
lay), using a 1 mM concentration of each primer. The
reaction was carried out at 37°C for 1 h and at 95°C for
5 min. Half of the cDNA was then amplified by PCR in a
total volume of 50 ml containing Taq pol buffer (10 mM
Tris–HCl (pH 9), 50 mM KCl, 0.1% Triton X-100), 1.5 mM
MgCl2, a 1 mM concentration of each of the primers used
or reverse transcription, and 1 unit of Taq polymerase
Promega). The reaction mixture was subjected to the
ollowing cycling parameters for 30 cycles: 94°C for 1in, 55°C for 0.5 min, and 72°C for 2 min, followed by
2°C for 5 min.
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145DIFFERENTIAL EXPRESSION OF IAP IN S49 LYMPHOMADNA isolation and hybridization of oligonucleotide
probes to DNA in dried agarose gels
High-molecular-weight DNA isolation was previously
described (Ehrlich et al., 1994). Hybridization of IAP oli-
gonucleotide probes to restriction enzyme-digested
genomic DNAs in dried gels was described in detail
(Lueders et al., 1993b). DNAs were digested with HindIII,
nd one-half of each sample was then digested with
aeII. The LS1 and LS2 oligonucleotides were used for
ybridization.
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